TIL of CFTR modulators, which can dramatically reduce the severity of the most common form of Cystic Fibrosis. Children and teens starting treatment in the UK today are predicted to have an average lifespan of 80+ years as long as they maintain treatment, up from ~35 years with only supportive care.